Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6608
Gene Symbol: SMO
SMO 		0.310 Biomarker disease BEFREE Clinicopathologically, tumors with mutations in TRAF7/AKT1 and SMO shared specific features: they were located in the anterior fossa, median middle fossa, or anterior calvarium, and most of them were meningothelial or transitional meningiomas. 27624470 2016
Entrez Id: 6608
Gene Symbol: SMO
SMO 		0.310 Biomarker disease CTD_human Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. 23334667 2013
Entrez Id: 1514
Gene Symbol: CTSL
CTSL 		0.310 Biomarker disease CTD_human Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors. 19747051 2010
Entrez Id: 1514
Gene Symbol: CTSL
CTSL 		0.310 AlteredExpression disease BEFREE The expression of cathepsins and inhibitors was not different between central and peripheral meningioma tissue or between histological subtypes of meningiomas, with the exception of cathepsin L, the level of which was significantly lower in transitional meningiomas. 15832773 2005
Entrez Id: 8314
Gene Symbol: BAP1
BAP1 		0.300 Biomarker disease CTD_human Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area. 25231345 2015
Entrez Id: 4771
Gene Symbol: NF2
NF2 		0.300 Biomarker disease CTD_human Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. 23334667 2013
Entrez Id: 207
Gene Symbol: AKT1
AKT1 		0.300 Biomarker disease CTD_human Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. 23334667 2013
Entrez Id: 8028
Gene Symbol: MLLT10
MLLT10 		0.300 Biomarker disease CTD_human Common variation at 10p12.31 near MLLT10 influences meningioma risk. 21804547 2011
Entrez Id: 1476
Gene Symbol: CSTB
CSTB 		0.300 Biomarker disease CTD_human Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors. 19747051 2010
Entrez Id: 1471
Gene Symbol: CST3
CST3 		0.300 Biomarker disease CTD_human Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors. 19747051 2010
Entrez Id: 3280
Gene Symbol: HES1
HES1 		0.300 Biomarker disease CTD_human Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres. 21127729 2010
Entrez Id: 5241
Gene Symbol: PGR
PGR 		0.300 Biomarker disease CTD_human Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors. 19747051 2010
Entrez Id: 5241
Gene Symbol: PGR
PGR 		0.300 Biomarker disease CTD_human Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy. 19731987 2010
Entrez Id: 210
Gene Symbol: ALAD
ALAD 		0.300 Biomarker disease CTD_human Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults. 16140629 2005
Entrez Id: 5728
Gene Symbol: PTEN
PTEN 		0.300 Biomarker disease CTD_human A novel germline mutation of PTEN associated with brain tumours of multiple lineages. 12085208 2002
Entrez Id: 5241
Gene Symbol: PGR
PGR 		0.300 Biomarker disease CTD_human Sphenoid wing meningioma progression after placement of a subcutaneous progesterone agonist contraceptive implant. 8008172 1994
Entrez Id: 4311
Gene Symbol: MME
MME 		0.010 AlteredExpression disease BEFREE Transitional meningiomas showed the highest positivity for CD10 expression, while the least positive was the meningiotheliomatous type. 31372897 2019
Entrez Id: 83990
Gene Symbol: BRIP1
BRIP1 		0.010 GeneticVariation disease BEFREE In addition, BRIP1 rs4968451T>G was associated with markedly meningothelial and transitional meningioma risk. 29581016 2018
Entrez Id: 6422
Gene Symbol: SFRP1
SFRP1 		0.010 GeneticVariation disease BEFREE AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry. 24096618 2013